A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Postpartum depression (PMD) occurs in roughly 10 % of postpartum women and negatively impacts the mother and her offspring, but there are few placebo-controlled studies of antidepressant treatment in this population. The objective was this study is to compare the selective serotonin reuptake inhibitor (SSRI) sertraline to placebo for treating PMD. This was a single-center, 6-week, randomized double-blind placebo-controlled trial of sertraline with a 1-week placebo lead-in. The participants (n = 38) were women with depression onset within 3 months of delivery; a subset (n = 27) met strict DSM-IV criteria for PMD (onset within 4 weeks of delivery). The participants were prescribed sertraline 50 mg or placebo daily to a maximum of 200 mg/day. Primary outcome variables were the Hamilton Depression Rating Scale (HAM-D) and Clinical Global Impressions (CGI) scores, which were used to determine the rates of response and remission. Sertraline produced a significantly greater response rate (59 %) than placebo (26 %) and a more than twofold increased remission rate (53 % vs. 21 %). Mixed models did not reveal significant group by time effects, although in the subset of women who met the DSM-IV criteria, there was a statistically significant group by time effect for the HAM-D, Hamilton Anxiety Rating Scale (HAM-A), and CGI. Women with PMD are more likely to have a remission of their depression with sertraline treatment, a finding that is more pronounced in women who have onset of depression within 4 weeks of childbirth. These data support the continued use of 4 weeks for the DSM-5 postpartum onset specifier for major depressive disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structured Clinical Interview for DSM-III-R Personality Disorders
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2012) · PsycTESTS Dataset · doi:10.1037/t07827-000 · Cited by 1,403
Cooper, P. J., & Murray, L. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.2.191 · Cited by 452
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
Griffin, L. D., & Mellon, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13512 · Cited by 387 · cited 1×
“SSRIs increase ALLO production from 5α-dihydroprogesterone (5α-DHP), an aspect of SSRI treatment that is particularly relevant in new parturient women (Griffin and Mellon 1999).”
BackgroundA meta-analysis of treatments for perinatal depression
Sockol, L. E., Epperson, C. N., & Barber, J. P. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.03.009 · Cited by 287 · cited 2×
“…therapy (IPT) alone or with antidepressant medications to be more effective than no psychotherapy, although not all studies were careful to limit enrollment to women with incident PMD and many included women with depression onset any time during the first postpartum year (Sockol et al. 2011).”
BackgroundResultSelf-citationPostpartum anxiety and depression: onset and comorbidity in a community sample
STUART, S., COUSER, G., SCHILDER, K., O'HARA, M. W., & GORMAN, L. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199807000-00006 · Cited by 258
Luisi, S., Petraglia, F., Benedetto, C., Nappi, R. E., Bernardi, F., Fadalti, M., Reis, F. M., Luisi, M., & Genazzani, A. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6675 · Cited by 237
Postpartum anxiety and maternal-infant health outcomes
Paul, I. M., Downs, D. S., Schaefer, E. W., Beiler, J. S., & Weisman, C. S. (2013) · Pediatrics · doi:10.1542/peds.2012-2147 · Cited by 221 · cited 1×
“Anxiety among postpartum women is an important clinical consideration, as it may influence healthcare utilization, breastfeeding duration, and parenting stress, among other factors (Misri et al. 2010; Paul et al. 2013).”
BackgroundInteractive Regulation of Affect in Postpartum Depressed Mothers and Their Infants: An Overview
Reck, C., Hunt, A., Fuchs, T., Weiss, R., Noon, A., Moehler, E., Downing, G., Tronick, E. Z., & Mundt, C. (2004) · Psychopathology · doi:10.1159/000081983 · Cited by 203
Yonkers, K. A., Lin, H., Howell, H. B., Heath, A. C., & Cohen, L. S. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0420 · Cited by 98
Recognizing and treating peripartum depression
Hübner-Liebermann, B., Hausner, H., & Wittmann, M. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0419 · Cited by 76
Cited by
Meltzer-Brody, S., Colquhoun, H., Riesenberg, R., Epperson, C. N., Deligiannidis, K. M., Rubinow, D. R., Li, H., Sankoh, A. J., Clemson, C., Schacterle, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31551-4 · Cited by 795
Self-citationPostpartum depression: Etiology, treatment and consequences for maternal care
Brummelte, S., & Galea, L. A. M. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.08.008 · Cited by 567
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
Kanes, S., Colquhoun, H., Gunduz-Bruce, H., Raines, S., Arnold, R., Schacterle, A., Doherty, J., Epperson, C. N., Deligiannidis, K. M., Riesenberg, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31264-3 · Cited by 479
Self-citationSex differences in depression: Insights from clinical and preclinical studies
Eid, R. S., Gobinath, A. R., & Galea, L. A. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.006 · Cited by 457
Putnam, K. T., Wilcox, M., Robertson-Blackmore, E., Sharkey, K., Bergink, V., Munk-Olsen, T., Deligiannidis, K. M., Payne, J., Altemus, M., Newport, J., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30136-0 · Cited by 308
Self-citation
Metadata
- Authors
- Hantsoo, L., Ward-O’Brien, D., Czarkowski, K. A., Gueorguieva, R., Price, L. H., & Epperson, C. N.
- Venue
- Psychopharmacology
- Published
- 2013-10-31
- Volume
- 231
- Issue
- 5
- Pages
- 939-948
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2085358740
- Cited by
- 91
- References
- 11
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. https://app.cochat.ai/papers/10.1007/s00213-013-3316-1
- The paper
- Hantsoo, L., Ward-O’Brien, D., Czarkowski, K. A., Gueorguieva, R., Price, L. H., & Epperson, C. N. (2014). A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology. https://doi.org/10.1007/s00213-013-3316-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.